Synthetic Biologics Appoints Deb Mathews, PharmD, as Vice President, Medical Affairs

Appointment Reflects Company's Late-Stage Clinical Focus and Plans to Prepare for Commercialization ROCKVILLE, Md., May 9, 2016 -- (Healthcare Sales & Marketing Network) -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a clinical stage company focused on ... Biopharmaceuticals, Gastroenterology, PersonnelSynthetic Biologics, gut microbiome, irritable bowel
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news